Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Greenberg

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
European Journal of Heart Failure|September 6, 2024
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trialRiccardo M Inciardi, Laura Staal, Beth Davison, et al.
Journal of the American College of Cardiology|November 23, 2013
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart FederationEloisa Arbustini, Navneet Narula, G William Dec, et al.
Global Heart|February 19, 2015
The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart FederationEloisa Arbustini, Navneet Narula, G William Dec, et al.
Nature Reviews. Cardiology|March 26, 2014
MOGE(S) nosology in low-to-middle-income countriesEloisa Arbustini, Navneet Narula, G William Dec, et al.
Journal of the American College of Cardiology|April 29, 2014
Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers?Eloisa Arbustini, Navneet Narula, G William Dec, et al.
Journal of Cardiac Failure|December 20, 2023
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF TrialLuca Monzo, Nicolas Girerd, João Pedro Ferreira, et al.
ESC Heart Failure|September 19, 2024
Clinical characteristics, diagnosis and short-term outcomes of COVID-19-associated acute myocarditis in ChinaHuihui Liu, Ping Zhou, Yan Huang, et al.
Circulation|September 4, 2008
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)Barry Greenberg, Barbara Czerska, Reynolds M Delgado, et al.
Journal of Cardiac Failure|June 3, 2008
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failureRoger J Hajjar, Krisztina Zsebo, Lawrence Deckelbaum, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 14, 2019
Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist DevicesRayan Yousefzai, Michela Brambatti, Hao A Tran, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
European Journal of Heart Failure|September 6, 2024
Impact of age on clinical outcomes and response to serelaxin in patients with acute heart failure: An analysis from the RELAX-AHF-2 trialRiccardo M Inciardi, Laura Staal, Beth Davison, et al.
Journal of the American College of Cardiology|November 23, 2013
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart FederationEloisa Arbustini, Navneet Narula, G William Dec, et al.
Global Heart|February 19, 2015
The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart FederationEloisa Arbustini, Navneet Narula, G William Dec, et al.
Nature Reviews. Cardiology|March 26, 2014
MOGE(S) nosology in low-to-middle-income countriesEloisa Arbustini, Navneet Narula, G William Dec, et al.
Journal of the American College of Cardiology|April 29, 2014
Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers?Eloisa Arbustini, Navneet Narula, G William Dec, et al.
Journal of Cardiac Failure|December 20, 2023
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF TrialLuca Monzo, Nicolas Girerd, João Pedro Ferreira, et al.
ESC Heart Failure|September 19, 2024
Clinical characteristics, diagnosis and short-term outcomes of COVID-19-associated acute myocarditis in ChinaHuihui Liu, Ping Zhou, Yan Huang, et al.
Circulation|September 4, 2008
Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM)Barry Greenberg, Barbara Czerska, Reynolds M Delgado, et al.
Journal of Cardiac Failure|June 3, 2008
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failureRoger J Hajjar, Krisztina Zsebo, Lawrence Deckelbaum, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 14, 2019
Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist DevicesRayan Yousefzai, Michela Brambatti, Hao A Tran, et al.
Pageof 19